Allosteric Switching of Agonist/Antagonist Activity by a Single Point Mutation in the Interluekin-1 Receptor Antagonist, IL-1Ra

Journal of Molecular Biology - United States
doi 10.1016/j.jmb.2013.03.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

IL-1Ra (Recombinant Human IL-1 Receptor Antagonist) in the Treatment of Rheumatoid Arthritis: The Efficacy

Reumatismo
Rheumatology
2011English

The Experimental Treatment of Corneal Graft Rejection With the Interleukin-1 Receptor Antagonist (IL-1ra) Gene

PLoS ONE
Multidisciplinary
2013English

Time-Dependent Antagonist-Agonist Switching in Receptor Tyrosine Kinase-Mediated Signaling

BMC Bioinformatics
BiochemistryApplied MathematicsComputer Science ApplicationsStructural BiologyMolecular Biology
2019English

Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonist

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2016English

Agonist--Antagonist--Muscarinic Receptor Ternary Complex.

Acta Chemica Scandinavica
1980English

NOP Receptor Mediates Anti-Analgesia Induced by Agonist–antagonist Opioids

Neuroscience
Neuroscience
2014English

Mutations Affecting the Glycine Receptor Agonist Transduction Mechanism Convert the Competitive Antagonist, Picrotoxin, Into an Allosteric Potentiator

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

IL-1 Beta Receptor Antagonist Efficacy in the Treatment of Idiopathic Recurrent Pericarditis

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2008English

Agonist and Antagonist Recognition by RIG-I, a Cytoplasmic Innate Immunity Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy